Digital weight loss and obesity treatment platforms
Strategic Profile
Noom's primary revenue stream is subscription-based with monthly, quarterly, and annual plans, complemented by B2B2C business selling Noom as a benefit to employers and health plans, and as the support arm of drug protocols. The company acquired Tailor Made Compounding in April 2026 to vertically integrate its compounding pharmacy supply chain and gain direct control over production of compounded GLP-1 and HRT medications. Strategic partnerships with major healthcare entities (Highmark, Castlight) and pharmaceutical companies position Noom for enterprise-scale adoption.
Cyborg Score Rationale
Noom has raised $624M in funding from investors like Sequoia Capital, Silver Lake and RRE Ventures, with a valuation of $3.7B. The company generated $368.9 million in annual revenue in 2026, demonstrating strong market traction. However, the company faces regulatory headwinds around GLP-1 telehealth prescribing and intense competition from telehealth giants expanding into obesity treatment.
Top Insights
Noom acquired Tailor Made Compounding in April 2026 to control its GLP-1 and HRT medication supply chain, signaling vertical integration into clinical fulfillment
Partnership with Highmark began in 2026 to offer Noom Weight Management to nearly 2 million eligible members, covering weight, diabetes prevention, and diabetes journeys
In September 2025, Noom launched a free tier with 'microhabits' programming, and in October 2025 added AI-powered Face Scan and Future Me features to the free tier
Noom Med pairs psychology-based behavioral coaching with GLP-1 prescriptions, targeting the tele-obesity market Goldman Sachs projects could reach approximately $100 billion by 2030
Named Competitors
Weight Watchers — Points-based weight management with coaching and anti-obesity medications
MyFitnessPal — Nutrition tracking and calorie counting with fitness logging
Vida Health — Medical weight loss and chronic condition management with anti-obesity medications
Calibrate — GLP-1 medication with personalized video coaching for weight management
Found — Obesity medicine with prescription medications and health coaching
Recent Developments
(April 2026) Acquired Tailor Made Compounding to vertically integrate GLP-1 and HRT compounding pharmacy supply chain
(April 2026) Partnered with b.well to launch Noom Health Record Connect, enabling seamless medical records integration
(October 2025) Expanded free tier with AI-powered Face Scan and Future Me health visualization features